The Comparison Women Deserve to Have

If you've ever been called back after a mammogram — and statistically, if you've been getting regular screening, you probably have — you know the particular anxiety of that phone call. The callback rate for screening mammography in the United States runs somewhere between 10 and 13 percent. The vast majority of those callbacks lead to additional imaging that ultimately finds nothing concerning. A smaller but still significant number lead to biopsies. An even smaller number lead to actual cancer diagnoses.

Those numbers represent an enormous amount of anxiety, unnecessary procedures, and healthcare cost. They also point to a fundamental limitation in the technology: mammography, even modern digital mammography with tomosynthesis, produces a lot of ambiguous results that require resolution. The false positive rate is high. The false negative rate — particularly in dense breast tissue — is real enough to be clinically significant.

3D breast CT enters this conversation not as a replacement for mammography in every context, but as a genuinely different imaging approach that addresses some of the structural limitations of projection-based imaging in ways that incremental improvements to mammography have not.

Understanding What You're Actually Comparing

Two Different Ways of Looking at the Same Organ

Mammography projects X-rays through the compressed breast and captures the attenuation pattern on a detector. The resulting image is a two-dimensional shadow of everything in the path of the beam — glandular tissue, fat, blood vessels, calcifications, and any lesions all layered on top of each other. The radiologist reading that image has to mentally separate overlapping structures that are physically superimposed on the same picture.

3D breast CT captures the breast as a true volume. The X-ray source rotates around the pendant, uncompressed breast, collecting data from hundreds of angles. Reconstruction algorithms synthesize those projections into a three-dimensional dataset. The radiologist then reads that dataset volumetrically — scrolling through cross-sectional slices, examining the breast in axial, sagittal, and coronal orientations, mentally reconstructing a spatial understanding that's directly visible rather than inferred.

This is not a subtle difference. It's a fundamental architectural distinction in how the imaging information is captured and presented.

Where Each Approach Has Relative Strengths

Conventional mammography has decades of outcome data behind it, established screening protocols, widespread availability, and relatively low cost. For women without dense breasts and without elevated risk factors, the sensitivity of standard mammography is genuinely adequate for routine screening in many clinical guidelines.

3D breast CT has stronger theoretical and emerging clinical advantages for specific populations — particularly women with dense breasts, women with prior augmentation, women with architectural distortion from previous surgery or biopsy, and potentially women at elevated risk who are seeking comprehensive supplemental screening. It also has a significant patient experience advantage due to the absence of compression.

The honest comparison acknowledges both what's established and what's still being studied — and right now, the evidence base for 3D breast CT, while promising, is still younger than the literature behind conventional mammography.

Dense Breasts: Where the Comparison Matters Most

A Problem That Affects Millions of US Women

The National Cancer Institute estimates that approximately 40 percent of women in the US have dense or extremely dense breast tissue as measured on mammography. In many states, women are now legally required to be informed if their mammography results indicate dense tissue — a policy change driven by patient advocacy and growing clinical recognition of the limitations of standard screening in this population.

Dense tissue reduces mammographic sensitivity — the ability of the test to detect cancer when it's present. Studies have consistently shown that mammography misses a meaningful proportion of cancers in women with extremely dense breasts, and that these women also have a higher underlying cancer risk than women with fatty breasts. It's the worst possible combination: higher risk, lower detection reliability.

3D breast CT addresses the dense tissue limitation more directly than any compression-based approach can, because volumetric imaging doesn't create the tissue overlap problem that makes dense breast mammography so challenging. A radiologist reviewing a breast CT dataset can examine each centimeter of breast tissue independently of the tissue layers above and below it — something fundamentally impossible with projection imaging.

The Supplemental Screening Landscape

The standard supplemental screening options currently available to women with dense breasts in the US are ultrasound and MRI. Both have real limitations in this context.

Screening ultrasound significantly increases the cancer detection rate in dense breast populations — but it also significantly increases the false positive rate, is highly operator-dependent, and is time-consuming. Breast MRI has the highest sensitivity of any available modality for breast cancer detection but requires IV contrast, is expensive, takes considerably longer than other modalities, and is not appropriate for all patients.

3D breast CT occupies a potentially interesting position in this landscape — more comprehensive than ultrasound, more practical than MRI for routine supplemental screening, and avoiding the compression and positioning challenges of mammography. The breast ct modality has real potential to fill a gap in the supplemental screening toolkit, particularly as the evidence base matures and access expands.

The Role of Dedicated Platforms in Clinical Adoption

Why Equipment Matters as Much as Technique

The quality of any imaging modality depends heavily on the equipment used to perform it. General-purpose whole-body CT scanners adapted for breast imaging cannot achieve the spatial resolution, dose efficiency, or patient positioning that a dedicated breast CT system provides. Clinical adoption of 3D breast CT as a serious screening and diagnostic tool is therefore directly tied to the availability of dedicated systems designed for that purpose.

The koning vera 3d breast ct platform represents this category of dedicated system — cleared by the FDA for breast imaging in the United States and designed specifically around the clinical requirements of breast tissue visualization. For radiology practices and imaging centers evaluating whether and how to incorporate dedicated breast CT into their service offerings, the distinction between dedicated and adapted systems is a primary consideration.

The growth of dedicated breast CT availability across US imaging centers will largely determine how quickly the technology transitions from a specialized option at academic medical centers to a more routinely accessible choice for women across the country.

What Radiologist Training and Experience Add

Volumetric breast CT datasets require reading skills that are somewhat different from traditional mammography interpretation. Radiologists who are experienced with breast MRI and tomosynthesis tend to adapt relatively quickly, but dedicated training in breast CT interpretation is genuinely important for optimizing diagnostic performance.

As more practices adopt dedicated 3D breast CT systems and more radiologists gain experience with the modality, the learning curve that currently exists will flatten — and the clinical performance data that supports broader adoption will continue to accumulate.

Making an Informed Decision as a Patient

Talking to Your Imaging Provider

The right imaging choice for any individual woman depends on a combination of factors: breast density, personal and family history, prior imaging history, access to different modalities in her geographic area, and insurance coverage. There is no single right answer for everyone.

What matters is having an informed conversation with your healthcare provider — one that includes an honest assessment of your individual risk factors and the available options in your area. If you have dense breasts or a history of inconclusive mammography results, asking specifically about 3D breast CT is worth doing.

Advocating for Better Imaging

The expansion of 3D breast CT access in the US will happen faster if patients ask for it. When women ask their providers about newer imaging options, when practices see demand for more comprehensive breast imaging, and when insurers see clinical evidence supporting coverage — the infrastructure for broader access develops.

You don't have to passively accept whatever imaging was available when the screening protocols you're following were last updated. You can ask what's new, what might be more appropriate for your specific situation, and what your options are.

You Deserve the Clearest Possible Picture

Breast cancer screening technology has improved meaningfully over the past decade, and 3D breast CT represents one of the more significant advances in how we visualize breast tissue. For women who have experienced the anxiety of dense breast callbacks, inconclusive results, or screening limitations, it's a development worth knowing about and worth asking for.

Talk to your doctor or radiologist about 3D breast CT today. Ask whether it's available near you, whether it's appropriate for your situation, and what it might offer beyond your current screening routine. Your health is worth the conversation.